Amarin Corp Plc (AMRN)

[rafunrafun]

Scripts for week ending December 23, 2022

Drug Industry TRx: -3.3% w/w; +10.2% y/y

Vascepa
TRx 62,936; -3.9% (-2,552) w/w; -15.3% y/y
NRx 29,011; -3.8% (-1,131) w/w; -14.0% y/y
Ref 33,925; -4.0% (-1,422) w/w; -16.4% y/y

Fake Vascepa
TRx 42,338; -4.1% (-1,832) w/w; As % of total V: 40.2%
NRx 19,715; -4.6% (-956) w/w; As % of total V: 40.5%
Ref 22,624; -3.7% (-875) w/w; As % of total V: 40.0%

Fake Vascepa by Manufacturer
Hikma - TRx 14,744; -661 w/w; Generic share 34.8%; Total V share 14.0%
Reddy - TRx 19,504; -993 w/w; Generic share 46.1%; Total V share 18.5%
Apotex - TRx 7,832; -155 w/w; Generic share 18.5%; Total V share 7.4%
Teva - TRx 259; -12 w/w; Generic share 0.6%; Total V share 0.2%

Vascepa + Fake Vascepa
TRx 105,275; -4.0% (-4,384) w/w; +6.9% y/y
NRx 48,726; -4.1% (-2,087) w/w; +1.3% y/y
Ref 56,549; -3.9% (-2,297) w/w; +12.3% y/y

Lovaza (Fake & Brand)
TRx 63,823; -4.2% (-2,809) w/w; +6.4% y/y
NRx 30,705; -6.8% (-2,232) w/w; +2.4% y/y
Ref 33,118; -1.7% (-577) w/w; +10.5% y/y